A single postoperative application of nitroglycerin ointment does not increase survival of cutaneous flaps and grafts

Dermatol Surg. 2000 May;26(5):425-7. doi: 10.1046/j.1524-4725.2000.99307.x.

Abstract

Background: Nitroglycerin is a vasodilator that has been reported to improve cutaneous flap and graft survival. It has not been tested in controlled studies.

Objective: We designed our study to test the effectiveness of a single postoperative application of nitroglycerin on flap and graft survival.

Methods: Eighty-eight surgical repairs received topical nitroglycerin and 85 received control ointment (polysporin). Treatment sites were evaluated on postoperative day 7 and assigned a percentage of surface area survival.

Results: There was no significant difference in the complication rate of flaps and grafts treated with nitroglycerin (12.5%) compared with those treated with control ointment (8.4%) (P = .244). Subset analysis of flaps as a group and grafts as a group were not meaningful because the complication rates were so low.

Conclusion: There is no survival increase of flaps and grafts treated with a single application of nitroglycerin ointment.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Disease-Free Survival
  • Double-Blind Method
  • Graft Survival / drug effects*
  • Humans
  • Mohs Surgery
  • Nitroglycerin / administration & dosage*
  • Ointments
  • Postoperative Care
  • Skin Neoplasms / surgery
  • Skin Transplantation*
  • Surgical Flaps*
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage*
  • Wound Healing / drug effects*

Substances

  • Ointments
  • Vasodilator Agents
  • Nitroglycerin